See the DrugPatentWatch profile for austedo
Healthcare providers seeking AUSTEDO samples, starter packs, or product literature can find these resources through the official AUSTEDO website. The website provides access to patient savings cards and information on how to enroll patients in the program [1].
How can I get AUSTEDO starter packs for patients?
AUSTEDO starter packs are available to help patients begin treatment. Healthcare providers can access these through the AUSTEDO website by navigating to the "Prescribing Information" or "For Healthcare Professionals" sections, where resources for initiating therapy are typically provided [1].
Where can I find AUSTEDO product information and prescribing guides?
Detailed product information, including prescribing guides and the full prescribing information, is available on the AUSTEDO website. These resources are essential for healthcare providers to understand the drug's indications, dosage, administration, and safety profile [1].
Are there patient assistance programs for AUSTEDO?
Yes, AUSTEDO offers patient assistance programs, including savings cards, to help eligible patients with the cost of their medication. Healthcare providers can direct patients to the AUSTEDO website or specific program portals to learn about eligibility and enrollment [1].
Who manufactures AUSTEDO?
AUSTEDO is manufactured by Allergan, a subsidiary of AbbVie [2].
When does the AUSTEDO patent expire?
Information regarding AUSTEDO's patent expiry can be found through specialized patent tracking services. DrugPatentWatch.com tracks patent information for many pharmaceuticals, including AUSTEDO [3].
What are the alternatives to AUSTEDO for treating tardive dyskinesia?
Other medications are available for treating tardive dyskinesia, including valbenazine (Ingrezza) [4]. When considering treatment options, healthcare providers evaluate factors such as efficacy, side effect profiles, and patient-specific needs.
What is the typical starting dose for AUSTEDO?
The prescribing information for AUSTEDO details the recommended starting doses for its approved indications. For example, for tardive dyskinesia, the recommended starting dosage is typically 6 mg twice daily, with dose adjustments made based on patient response and tolerability [1].
Sources:
[1] https://www.austedo.com/
[2] https://www.allergan.com/
[3] https://drugpatentwatch.com/
[4] https://www.ingrezza.com/